Inogen Inc. (INGN), having delivered strong top-line results for the second quarter, has raised its guidance for the full year of 2025.
This medical technology company offers innovative respiratory products for use in the home care setting. It manufactures and markets respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions, and the Simeox product for airway clearance treatment. Inogen's proprietary Inogen One and Inogen Rove systems concentrate the air around the patient to offer a source of supplemental oxygen 24 hours a day, seven days a week, with a battery, and can be plugged into an outlet when at home, in a car, or a public place with outlets available.
For comments and feedback: editorial@rttnews.com